CNK Earnings

CNK reported its FY2025Q4 earnings on 2026-02-23, showcasing a revenue of 0.00 against an estimate of 875.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.27 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CNK's FY2025Q4 earnings announcement on 2026-02-23, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CNK's stock price tends to shift by an average of -3.02% in the 10 days leading up to earnings and -0.19% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CNK’s annual revenue to reach 863.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.68% and EPS estimates Revise Downward by -3.73% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CNK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.68%, while EPS estimates moved Revise Downward by -3.73% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CNK's stock price typically moves by -3.02% in the 10 days before its earnings and -0.19% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 863.00M.

The earnings call summary and Q&A section provide a positive sentiment overall. The company projects strong future film releases, revenue growth, and premium offerings expansion, which are expected to enhance customer experiences and drive attendance. Despite some headwinds, the management's optimistic guidance, strategic pricing, and loyalty program growth are likely to positively impact the stock. The company's sound financial health and strategic initiatives to expand market share further support a positive outlook. Given the market cap, the stock is likely to see a positive movement of 2% to 8% over the next two weeks.